HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Name: HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial
Published: 2019
License: Public Domain

Sun Yat-sen University · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

hepatocellular-carcinoma

hepatocellular carcinoma, hepatic arterial infusion chemotherapy, 2400 mg/m² 5-fu, 1200 mg/m² 5-fu, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Related documents